The arc of HIV history has been developing over the last four decades. In the early days there was much we did not know, but as teams of physicians, researchers and patients increased their understanding of the disease, progress was made. Early efforts with repurposed cancer drugs gave way to numerous viral inhibitor combinations. On a parallel course, attempts to… [Read More]
The Berlin Patient’s Success Produces A Flurry of Activity With an important milestone in the rearview mirror and clarity on the course ahead, the Berlin patient’s success invigorated new efforts to eliminate the CCR5 receptor. Stem cell replacement cannot be practiced widely because of its risk, complexity and requirement for a highly compatible donor. Many patients who received bone marrow… [Read More]
More than 32 million people have died from AIDS-related illnesses since the start of the epidemic in 1981, making HIV/AIDS one of the greatest public health threats the world has known. Since it was first identified nearly 40 years ago, trillions of dollars have been spent by governments and private individuals on efforts to find effective treatments, vaccines, and a… [Read More]
Contributing Author John Vandermosten, Senior Biotechnology Analyst This is the second installment of our series on the Arc of HIV History which examines the earliest emergence of HIV and the progress that has been made until today. In Part 2 we look at the genesis of the first approved HIV drug and the first cure of HIV in the Berlin Patient…. [Read More]
A Message From the CEO of American Gene Technologies Timothy Ray Brown – March 11, 1966 – September 29, 2020 Timothy Ray Brown was both a person and a turning point in the arc of HIV history. Timothy received a bone marrow transplant and became functionally cured; a symbol to the world that a cure for HIV was possible. He… [Read More]
Subscribe to our newsletter to keep up to date with all the latest news about AGT!